Malignant Hyperthermia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 30: | Line 30: | ||
[https://www.bjanaesthesia.org/article/S0007-0912(22)00496-2/fulltext Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia] | [https://www.bjanaesthesia.org/article/S0007-0912(22)00496-2/fulltext Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia] | ||
[https://bjan-sba.org/article/doi/10.1016/j.bjane.2021.07.038 Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study] | |||
Revision as of 22:06, 14 April 2023
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
https://link.springer.com/chapter/10.1007/978-4-431-68346-9_1
See also http://www.mhaus.org
Malignant hyperthermia 2020 Guideline from the Association of Anaesthetists P. M. Hopkins T. Girard S. Dalay B. Jenkins A. Thacker M. Patteril E. McGrady First published: 05 January 2021 https://doi.org/10.1111/anae.15317
http://malignanthyperthermia.org.au/resource-kit/
https://twitter.com/hypoxicchicken/status/1232963055467712514?s=21
Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing. Anesthesiology. 2022 Jun 1;136(6):940-953. PMID: 35285867